| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | REATA PHARMACEUTICALS INC | 13,058 | 285,000 | 0.07% | ||
| 2 | MEI PHARMA INC | 580,401 | 836,000 | 0.20% | ||
| 3 | KALVISTA PHARMACEUTICALS INC | 329,942 | 2,333,000 | 0.56% | ||
| 4 | XENON PHARMACEUTICALS INC | 320,061 | 2,465,000 | 0.59% | ||
| 5 | OCERA THERAPEUTICS INC | 1,248,064 | 2,621,000 | 0.62% | ||
| 6 | INVUITY INC | 1,080,272 | 6,212,000 | 1.48% | ||
| 7 | PARATEK PHARMACEUTICALS INC | 512,366 | 7,890,000 | 1.88% | ||
| 8 | APPLIED GENETIC TECHNOL CORP | 1,452,216 | 13,579,000 | 3.24% | ||
| 9 | CIDARA THERAPEUTICS INC | 1,356,813 | 14,111,000 | 3.36% | ||
| 10 | EIGER BIOPHARMACEUTICALS INC | 1,599,592 | 18,635,000 | 4.44% | ||
| 11 | OBALON THERAPEUTICS INC | 2,453,338 | 21,712,000 | 5.18% | ||
| 12 | MACROGENICS INC | 1,074,316 | 21,959,000 | 5.24% | ||
| 13 | GLAUKOS CORP | 1,018,362 | 34,930,000 | 8.33% | ||
| 14 | TESARO INCORPORATED | 2,021,403 | 271,838,000 | 64.82% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000950123-17-001438, filed 2017.02.10).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
